Go Back
IM

IMMUNEEL THERAPEUTICS PRIVATE LIMITED

Immuneel Therapeutics

U24230KA2018PTC119691

Get Comprehensive Report

₹1,999.00 ₹3,998.00
Suggest Edit Last updated: Feb 6, 2025
Key Metrics
  • No. of Employees47
  • Founded Year 2018
  • Company StagePrivate Limited Company
  • Total Funding₹306.16 Cr
  • Industry

  • Headquarter
  • Company StatusActive
About Immuneel Therapeutics

Immuneel Therapeutics Private Limited is a pioneering startup company leading the charge in cell therapy and personalized immunotherapy for patients in India.


They Pursue, with Purpose, to serve our Patients (3 Ps) by Connecting within, Collaborating globally and Creating (3 Cs) solutions. Their flexible, diverse, and vibrant team is bringing together best practices and innovations in the field of cell and gene therapy.

Business Model

CAR-T cell therapies use genetically (Cell and gene therapy) modified human immune cells to fight cancer.

Top Competitors
PC
Pristyn CareU85300HR2018PTC075460
QU
Qure.aiU74999MH2016PTC283891
3H
3hcareU85200DL2021PTC379169
PR
PractoU72900KA2008PTC046374
Immuneel Therapeutics Funding Details
Funding Highlights
Latest Funding RoundSeries A
Total Funding Raised₹306.16 Cr
No. of Investments Made0
Total No. of Acquisitions0
Lead Investors5
Investors
  • Eight Road Ventures, True North, Glentec, Khosla Ventures, Syngene
Funding Details
TheKredible's detailed funding report contains info about Funding raised by the company along with Lead Investors, Investors, Shareholding Strcuture, and its Investments & Acquisitions.
₹799.00 ₹1,598.00
Funding History
TheKredible's 'Funding History' report provides deep insights of Funding with list of Lead Investors
₹399.00 ₹798.00
Funding Per Year
A Funding report of the company's overall funding on yearly basis, segregated by the team TheKredible.
₹199.00 ₹398.00
Immuneel Therapeutics Financial Details
Financial Highlights
FY 2023-24 Revenue₹2.25 Cr
FY 2023-24 Expenses₹56.01 Cr
FY 2023-24 Profit/Loss-₹53.77 Cr
Net Cash Flow From OperationsUndisclosed
Full Financial Details
Detailed report containing info about Business Model, year-wise Financial Comparison, Ratio Analysis and detailed Revenue and Expense breakdowns.
₹799.00 ₹1,598.00
Financial Comparison
A detailed report of year-wise Financial Comparison of the company
₹430.00 ₹860.00
Revenue Breakdown
A report and breakdown of the company's year-wise revenue streams.
₹399.00 ₹798.00
Expense Breakdown
A report and breakdown of the company's year-wise expenditures.
₹399.00 ₹798.00
Shareholding Structure
Team at TheKredible has gone through several ROC filings and portrayed Shareholding Structure of the company.
₹499.00 ₹998.00
Financial Ratio
Analysis of Financial Ratios which gives quick insights about the company's profitability and capital efficiency.
₹199.00 ₹398.00
Immuneel Therapeutics Key People
People Metrics
Current Core Team3
Board Members/Directors5

Core Team

KM
Kiran Mazumdar ShawCo-Founder
SM
Siddhartha MukherjeeCo-Founder
KP
Kush ParmarCo-Founder

Board Members/Directors

KM
Kiran Mazumdar ShawDirector
SM
Siddhartha MukherjeeDirector
PV
Prem Venkatchalam PavoorDirector
RR
Ranjan Ramdas PaiDirector
AA
Arun AnandDirector
Immuneel Therapeutics Documents

AY - 2018-19

Profit and Loss statement - Immuneel Therapeutics - 2018-19.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Immuneel Therapeutics for FY 2018-19.
₹249.00 ₹498.00
Balance Sheet - Immuneel Therapeutics - 2018-19.pdf
TheKredible's experts has summarized the Balance Sheet of Immuneel Therapeutics for FY 2018-19.
₹249.00 ₹498.00

AY - 2019-20

Profit and Loss statement - Immuneel Therapeutics - 2019-20.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Immuneel Therapeutics for FY 2019-20.
₹249.00 ₹498.00
Balance Sheet - Immuneel Therapeutics - 2019-20.pdf
TheKredible's experts has summarized the Balance Sheet of Immuneel Therapeutics for FY 2019-20.
₹249.00 ₹498.00

AY - 2020-21

Profit and Loss statement - Immuneel Therapeutics - 2020-21.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Immuneel Therapeutics for FY 2020-21.
₹249.00 ₹498.00
Balance Sheet - Immuneel Therapeutics - 2020-21.pdf
TheKredible's experts has summarized the Balance Sheet of Immuneel Therapeutics for FY 2020-21.
₹249.00 ₹498.00

AY - 2021-22

Profit and loss statement - Immuneel Therapeutics - 2021-22.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Immuneel Therapeutics for FY 2021-22
₹249.00 ₹498.00
Balance sheet - Immuneel Therapeutics - 2021-22.pdf
TheKredible's experts has summarized the Balance Sheet of Immuneel Therapeutics for FY 2021-22
₹249.00 ₹498.00

AY - 2022-23

Profit and loss statement - Immuneel Therapeutics - 2022-23.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Immuneel Therapeutics for FY 2022-23
₹249.00 ₹498.00
Balance sheet - Immuneel Therapeutics - 2022-23.pdf
TheKredible's experts has summarized the Balance Sheet of Immuneel Therapeutics for FY 2022-23
₹249.00 ₹498.00

AY - 2023-24

Profit and loss statement - Immuneel Therapeutics - 2023-24.pdf
TheKredible's experts has summarized the Profit and Loss Statement of Immuneel Therapeutics for FY 2023-24
₹249.00 ₹498.00
Balance sheet - Immuneel Therapeutics - 2023-24.pdf
TheKredible's experts has summarized the Balance Sheet of Immuneel Therapeutics for FY 2023-24
₹249.00 ₹498.00

Subscribe to our newsletter to stay updated

Weekly Funding Reports
Funding Report
Weekly Funding Report [05 May- 10 May, 2025]
Monthly Funding Reports
Funding Report
Indian startups' funding falls to $745 Mn in April

Get your Customised Report

With an exclusive 20% off on your order

Latest Industry Reports
Industry Report
HealthTech’s Rebound: After a Downturn, HealthTech...